Life Sciences Outlook 2012 Dutch biotech companies ... - NautaDutilh
Life Sciences Outlook 2012 Dutch biotech companies ... - NautaDutilh
Life Sciences Outlook 2012 Dutch biotech companies ... - NautaDutilh
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The Netherlands<br />
The Netherlands<br />
John Allen<br />
Christiaan de Brauw<br />
Partner<br />
Amsterdam<br />
T: +31 20 71 71 869<br />
M: +31 62 02 10 606<br />
E: john.allen@nautadutilh.com<br />
John Allen specializes in intellectual property law<br />
(in particular patent litigation, licensing and advice).<br />
John argued the first case before the European<br />
Court of Justice on the scope of protection of a<br />
patent covering DNA sequences and molecules<br />
(Case C-428/08, Monsanto vs Cefetra). He has also<br />
litigated a number of pan-European patent disputes<br />
in the life sciences sector. John frequently assists in<br />
licensing and spin-out disputes.<br />
Partner, Head of <strong>Life</strong> <strong>Sciences</strong> Team<br />
Amsterdam<br />
T: +31 20 71 71 698<br />
M: +31 65 36 80 786<br />
E: christiaan.debrauw@nautadutilh.com<br />
Christiaan de Brauw specializes in mergers and<br />
acquisitions and corporate law. He focuses in<br />
particular on public M&A work and on M&A/<br />
corporate, corporate governance and capital<br />
markets advice and transactions for life sciences<br />
clients. Christiaan is a member of the American<br />
Bar Association and a fellow of the American Bar<br />
Foundation, in addition to publishing and teaching<br />
regularly on M&A-related topics.<br />
<strong>Life</strong> <strong>Sciences</strong> <strong>Outlook</strong> <strong>2012</strong> <strong>Dutch</strong> <strong>biotech</strong> <strong>companies</strong>: from start-up to exit<br />
47